Abstract:Chao Wang, 1, &ast Mei Zhao, 2, &ast Yuanyuan Yue, 3 Chao Hu, 2 Chunqiu Zhou, 2 Zhongyi Zhang, 2 Yunliang He, 4 Yaqi Luo, 4 Tao Shen, 2 Sijie Dang, 4 Yang Yang, 4 Yong Zhang 2, 4 1 Traditional Chinese Medicine Department, Qitai Hospital of the Sixth Division, Xinjiang, 831899, People's Republic of China; 2 College of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, 611137, People's Republic of China; 3 Department of Ultrasound, Chengdu First People's Hospital, Chengdu, 610095, People's Republic of China; 4 Institute of Traditional Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, 610014, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yong Zhang; Yang Yang, Institute of Traditional Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, People's Republic of China, Email ; Background: Modified Suanmei-Tang (MST) comprises four plants common to both traditional Chinese medicine and culinary applications, and it can potentially alleviate metabolic-associated fatty liver disease (MAFLD) triggered by a high-fat diet (HFD). Purpose: This research aims to investigate the impact and underlying mechanisms of MST in ameliorating MAFLD caused by an HFD. Methods: UHPLC-Q-Orbitrap-MS/MS was used to determine the constituents of MST and to evaluate its effects on MAFLD mouse models. Transcriptomics, network pharmacology, and bioinformatics analysis (including Kyoto Encyclopedia of Genes and Genomes and Gene Set Enrichment Analysis) were utilized to further clarify the mechanisms by which MST acts on MAFLD. The experimental methods included ELISA, real time quantitative PCR (RT-qPCR), Western blot, immunohistochemistry, molecular docking, and metabolomics. Transcriptomics was integrated with metabolomics to find correlations between differentially expressed genes and metabolites, and crucial genes were validated through RT-qPCR. Results: A total of 23 components of MST were identified. The formulation was found to alleviate metabolic disorders, obesity, insulin resistance, inflammation, and oxidative stress in mice with MAFLD. The findings indicate that MST promoted autophagy by suppressing phosphorylation in the PI3K/AKT/mTOR pathway and enhancing lipid management in the livers of MAFLD mice. Conclusion: MST could effectively improve lipid metabolism disorders and liver lipid deposition in MAFLD mice, and its mechanism might be related to regulating the PI3K/AKT/mTOR pathway to improve autophagy. Keywords: modified Suanmei-Tang, MAFLD, transcriptomics, network pharmacology, metabolomics Graphical Metabolic-associated fatty liver disease (MAFLD) affects roughly 25% of people worldwide and is a major factor in the development of cirrhosis and liver cancer. 1 However, due to the extremely complex etiology and pathogenesis of MAFLD, there is a lack of targeted pharmaceutical interventions. The multiple-hit hypothesis offers insight into the genesis and advancement of MAFLD, positing that genetically predisposed individuals experience a series of insults, including lipid toxicity, insulin resistance (IR), mitochondrial and endoplasmic reticulum dysfunction, oxidative stress, and disrupted autophagy and inflammasomes. 2,3 Furthermore, numerous research findings have shown that disruptions in liver lysosomes and autophagy are connected to steatosis in MAFLD at the organ and cellular levels, highlighting autophagy as a promising therapeutic target. 4,5 Traditional Chinese medicine (TCM) is characterized by unique therapeutic methods that are vital for promoting health and addressing diseases. TCM formulas typically consist of a combination of herbs that produce synergistic effects, resulting in favorable therapeutic results. Numerous TCM recipes have demonstrated beneficial outcomes in MAFLD cases, specifically by improving lipid metabolism and reducing inflammation, oxidative damage, and cellular death and decay. 6,7 Modified Suanmei-Tang (MST), a well-known traditional Chinese medicine blend, consists of Wumei (Prunus mume [Sieb.] Sieb. et Zuce), Shanzha (Crataegus pinnatifida Bunge), Chenpi (Citrus reticulata Blanco), and Gancao (Glycyrrhiza uralensis Fisch). Modern pharmacology has indicated that Wumei, Chenpi, and Gancao exhibit potent anti-inflammatory and antioxidant properties, thus mitigating tissue damage. 8–10 Additionally, Shanzha has been shown to ameliorate HFD-induced endothelial dysfunction by facilitating lipid expulsi -Abstract Truncated-

Artemisia Capillaris Thunb. Water Extract Alleviates Metabolic Dysfunction-associated Steatotic Liver Disease Disease by Inhibiting Mir-34A-5p to Activate Sirt1-mediated Hepatic Lipid Metabolism

Aqueous extract of Artemisia capillaris improves non-alcoholic fatty liver and obesity in mice induced by high-fat diet

Atractylodes Lancea and Its Constituent, Atractylodin, Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via AMPK Activation

Clinopodium gracile Alleviates Metabolic Dysfunction-Associated Steatotic Liver Disease by Upregulating Peroxisome Proliferator-Activated Receptor α and Inhibiting Mitochondrial Oxidative Damage

Acteoside From Ligustrum robustum (Roxb.) Blume Ameliorates Lipid Metabolism and Synthesis in a HepG2 Cell Model of Lipid Accumulation

Allyl Isothiocyanate Ameliorates Lipid Accumulation and Inflammation in Nonalcoholic Fatty Liver Disease Via the Sirt1/AMPK and NF-κB Signaling Pathways.

Investigation of the Lipid-Lowering Activity and Mechanism of Three Extracts from Astragalus membranaceus, Hippophae rhamnoides L., and Taraxacum mongolicum Hand. Mazz Based on Network Pharmacology and In Vitro and In Vivo Experiments

Exploration of the potential mechanism of aqueous extract of Artemisia capillaris for the treatment of non-alcoholic fatty liver disease based on network pharmacology and experimental verification

Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against metabolic dysfunction-associated steatotic liver disease

Upregulation of Hepatic Glutathione S-Transferase Alpha 1 Ameliorates Metabolic Dysfunction-Associated Steatosis by Degrading Fatty Acid Binding Protein 1

Natural Linoleic Acid from Marine Fungus Eutypella sp. F0219 Blocks KEAP1/NRF2 Interaction and Ameliorates MASLD by Targeting FABP4

Integration of pharmacodynamics, network pharmacology and metabolomics to elucidate effect and mechanism of<i> Artemisia</i><i> capillaris</i> Thunb. in the treatment of jaundice

Integrated Lipidomic and transcriptomics to explore the effects of ethyl acetate extract of Herpetospermum pedunculosum on nonalcoholic fatty liver disease in mice

Mechanism of Astragalus membranaceus Alleviating Acquired Hyperlipidemia Induced by High-Fat Diet through Regulating Lipid Metabolism

Protective Effect of Modified Suanmei-Tang on Metabolic-Associated Fatty Liver Disease: An Integrated Strategy of Network Pharmacology, Metabolomics, and Transcriptomics

Artemisia argyi ethanol extract ameliorates nonalcoholic steatohepatitis-induced liver fibrosis by modulating gut microbiota and hepatic signaling

AMPK-activator ATX-304 reduces oxidative stress and improves MASLD via metabolic switching

TFEB activator tanshinone IIA and derivatives derived from Salvia miltiorrhiza Bge. Attenuate hepatic steatosis and insulin resistance

Calenduloside E Ameliorates Non-Alcoholic Fatty Liver Disease Via Modulating a Pyroptosis-Dependent Pathway.

Phocaeicola vulgatus alleviates diet-induced metabolic dysfunction-associated steatotic liver disease progression by downregulating histone acetylation level via 3-HPAA

EMC10 Modulates Hepatic ER Stress and Steatosis in an Isoform Specific Manner